SUMMARY Human herpesvirus 6 (HHV-6) is a betaherpesvirus that is closely related to
human cytomegalovirus. It was discovered in 1986, and HHV-6 literature has expanded …

Graft-versus-host disease (GVHD) is an important cause of morbidity and mortality after
allogeneic hematopoietic cell transplantation (HCT). Many studies have suggested that …

Abstract Background Human herpesvirus 6 (HHV-6) is increasingly recognized as an
opportunistic and potentially life-threatening pathogen in recipients of allogeneic stem cell …

Human herpesvirus 6 (HHV-6) reactivation has been associated with acute graft-versus-host-
disease (aGVHD), cytomegalovirus reactivation, and mortality after allogeneic hematopoietic …

Abstract Human herpesvirus 6 (HHV-6) infection was studied in 82 bone marrow transplant
(BMT) recipients (72 allogeneic, 10 autologous). All recipients and 30 donors were …

This study investigated the impact of human herpesvirus type 6 (HHV6) reactivation within
100 days of allogeneic stem cell transplantation (allo-SCT) on patient outcomes. HHV6 …

We studied 228 consecutive stem cell transplant recipients, screened for reactivation of
human herpesvirus‐6 (HHV‐6) in peripheral blood and other specimens as clinically …

Abstract Human herpesvirus (HHV)–6 and HHV–7 loads were evaluated retrospectively in
peripheral blood mononuclear cells (PBMC) from 78 recipients of stem cell transplantation …

ABSTRACT A novel nucleic acid amplification method, termed loop-mediated isothermal
amplification (LAMP), which amplifies DNA with high specificity, efficiency, and rapidity …

We prospectively evaluated the incidence of human herpesvirus 6 (HHV-6) DNAemia after
allogeneic hematopoietic stem cell transplantation (HSCT) using quantitative plasma real …